Visium Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Visium Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,092	Closed	-$461K	–	548
2015 Q4	$461K	Buy	4,092 +2,010	+97%	+$218K	0.01%	494
2015 Q3	$211K	Buy	+2,082	New	+$250K	﹤0.01%	793
2015 Q1	–	Sell	-5,100	Closed	-$516K	–	1099
2014 Q4	$516K	Buy	+5,100	New	+$496K	0.01%	738
2014 Q3	–	Sell	-6,000	Closed	-$514K	–	1117
2014 Q2	$514K	Buy	+6,000	New	+$473K	0.01%	714

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Visium Asset Management's IBB Position: Q1 2016 in Review

Visium Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 4,092 shares — an estimated $461K sold.

Visium Asset Management first reported a position in IBB in Q2 2014 and held it in 4 quarters. The position peaked at $516K in Q4 2014. 415 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

Visium Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
Visium Asset Management sold 4,092 iShares Biotechnology ETF shares in Q1 2016, an estimated $461K.
Visium Asset Management first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 4 quarters.
Visium Asset Management's iShares Biotechnology ETF position peaked at $516K in Q4 2014.
415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Visium Asset Management's 13F filing for Q1 2016, filed 16 May 2016.